STOCK TITAN

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Avadel Pharmaceuticals plc (Nasdaq: AVDL) will participate in the Jefferies London Healthcare Conference on November 14 and the Piper Sandler 35th Annual Healthcare Conference on November 29, with live webcasts and archived recordings available on the company's Investor Relations website.
Positive
  • None.
Negative
  • None.

DUBLIN, Ireland, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences:

  • Jefferies London Healthcare Conference: Fireside chat on Tuesday, November 14 at 5:00 p.m. GMT / 12:00 p.m. ET.
  • Piper Sandler 35th Annual Healthcare Conference: Fireside chat on Wednesday, November 29 at 11:30 a.m. ET.

A live webcast of these events, as well as archived recordings, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following each conference.

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ™, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. For more information, please visit www.avadel.com.

Investor Contact:
Courtney Turiano
Stern Investor Relations, Inc.
Courtney.Turiano@sternir.com
(212) 698-8687

Media Contact:
Lesley Stanley
Real Chemistry
lestanley@realchemistry.com 
(609) 273-3162


FAQ

When is Avadel Pharmaceuticals plc participating in upcoming investor conferences?

Avadel Pharmaceuticals plc will participate in the Jefferies London Healthcare Conference on November 14 and the Piper Sandler 35th Annual Healthcare Conference on November 29.

Where can I access the live webcast and archived recordings of the conferences?

The live webcast and archived recordings of the conferences will be available on Avadel's Investor Relations website, investors.avadel.com, for 90 days following each conference.

Avadel Pharmaceuticals plc Ordinary Share

NASDAQ:AVDL

AVDL Rankings

AVDL Latest News

AVDL Stock Data

1.81B
66.69M
4.9%
64.09%
11.48%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
DUBLIN

About AVDL

avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.